Longevity Health Holdings, Inc. (XAGE)
0.3102
-0.03
(-8.76%)
USD |
OTCM |
Jun 08, 16:00
Longevity Health Holdings SG&A Expense (Quarterly) : 1.495M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 7.171M |
| ProText Mobility, Inc. | 0.012M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Agenus, Inc. | 6.86M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |